EGFR and cancer: In addition, specific Grb7 peptides targeting the SH2 domain of Grb7, which blocks EGF/EGFR signal-mediated ERK activation [50], or knockdown of GRB7, which ablates MMP-9 expression [49], attenuate cancer invasion.